Patent · US Active

Treatment and prevention of tissue damage

US8039222B2 · kind B2 · utility

0Cited by

5References

12Claims

0Family size

Assignee

PENTRAXIN THERAPEUTICS LIMITED · GB

Inventor

Mark B. Pepys · London, GB

Key dates

Filing date	Mar 27, 2008
Grant date	Oct 18, 2011
Priority date	—
Expiry date	Dec 13, 2029

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for the treatment or prevention of tissue damage in a subject having an inflammatory and/or tissue damaging condition, which comprises administering to the subject an effective amount of a compound capable of inhibiting the binding of C-reactive protein (CRP) to an autologous or extrinsic ligand.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.